In addition, we also analyzed the expression levels of DLAT, IDH3B, and MAP3K4 in HCC (Figure 3D) and their prognostic value in different clinical subgroups: T3 and T4 stage, pathological stage III and IV, fibrosis Ishak score 3–6, and Child–Pugh grade B and C. The results indicated that the lower expression of the three genes might be correlated with better prognosis in advanced patients (Figure 3E–G, Figure S1). The gene discussed is MAP3K4; the disease is hepatocellular carcinoma.